Citigroup Inc Pacific Biosciences Of California, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Citigroup Inc holds 229,100 shares of PACB stock, worth $405,507. This represents 0.0% of its overall portfolio holdings.

Number of Shares

229,100

Previous 117,403 95.14%

Holding current value

$405,507

Previous $160,000 143.13%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$1.2 - $2.17 $134,036 - $242,382	111,697 Added 95.14%	229,100 $389,000
Q2 2024 Aug 12, 2024	BUY	$1.36 - $3.65 $90,299 - $242,349	66,397 Added 130.17%	117,403 $160,000
Q1 2024 May 10, 2024	SELL	$3.52 - $9.59 $18,680 - $50,894	-5,307 Reduced 9.42%	51,006 $191,000
Q4 2023 Feb 09, 2024	SELL	$5.97 - $10.36 $391,345 - $679,118	-65,552 Reduced 53.79%	56,313 $552,000
Q3 2023 Nov 09, 2023	SELL	$8.23 - $13.93 $119,170 - $201,706	-14,480 Reduced 10.62%	121,865 $1.02 Million
Q2 2023 Aug 10, 2023	BUY	$9.97 - $14.05 $1.18 Million - $1.67 Million	118,613 Added 668.92%	136,345 $1.81 Million
Q1 2023 May 11, 2023	SELL	$7.94 - $12.02 $14,585 - $22,080	-1,837 Reduced 9.39%	17,732 $205,000
Q4 2022 Feb 09, 2023	SELL	$5.67 - $11.2 $40,744 - $80,483	-7,186 Reduced 26.86%	19,569 $160,000
Q3 2022 Nov 10, 2022	SELL	$3.93 - $8.57 $71,345 - $155,579	-18,154 Reduced 40.42%	26,755 $155,000
Q2 2022 Aug 10, 2022	BUY	$4.02 - $10.43 $10,564 - $27,410	2,628 Added 6.22%	44,909 $198,000
Q1 2022 May 12, 2022	SELL	$8.43 - $20.9 $378,380 - $938,096	-44,885 Reduced 51.49%	42,281 $384,000
Q4 2021 Feb 10, 2022	BUY	$19.26 - $30.08 $490,263 - $765,686	25,455 Added 41.25%	87,166 $1.78 Million
Q3 2021 Nov 10, 2021	BUY	$24.86 - $35.02 $1.53 Million - $2.16 Million	61,711 New	61,711 $1.58 Million

Others Institutions Holding PACB

# of Institutions

255

Shares Held

228M

Call Options Held

745K

Put Options Held

1.23M

View Full List

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $398M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

More about PACB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account